Yahoo Web Search

Search results

1. • HC Wainwright Comments on Poseida Therapeutics, Inc.’s Q3 2025 Earnings (NASDAQ:PSTX)

     ETF DAILY NEWS· 3 days ago

     Poseida Therapeutics, Inc. (NASDAQ:PSTX – Free Report) – HC Wainwright issued their Q3 2025 earnings per share estimates for shares of Poseida Therapeutics in a research report issued to clients ...

2. • Small Business - Cordele Dispatch | Cordele Dispatch

     Cordele Dispatch· 4 days ago

     Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by deregulated transcription, today announced the ...

3. • Small Business - Shelby County Reporter | Shelby County Reporter

     The Shelby County Reporter· 5 days ago

     SAN MATEO, Calif. and CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by deregulated transcription

4. • Biogen says hello to HI-Bio, inking $1.15B buyout to expand in immunology

     FierceBiotech· 5 days ago

     Biogen is placing a $1.15 billion bet on Chris Viehbacher’s diversification vision. The upfront payment has secured Biogen a deal to buy Human Immunology Biosciences (HI-Bio), a biotech that ...